FBIO 240816 2.50C (FBIO240816C2500) Stock Options, News & Quotes

US OptionsDetailed Quotes

FBIO240816C2500

Watchlist

0.05
-0.30-85.71%

15min DelayTrading Jul 29 11:46 ET

0.15High0.05Low

Intraday

5D
Daily

News

Fortress Biotech Secures New Credit Facility, Grants Warrants
TipRanksJul 25 17:49 ET
Fortress Biotech Secures Loan of up to $50M
Seeking AlphaJul 25 08:45 ET
Express News | Fortress Biotech Inc - Repaid Its Prior $50 Mln Term Loan With Oaktree.
ReutersJul 25 08:31 ET
Express News | Fortress Biotech Reduces Total Debt and Enters Into New $35 Million Term Loan With Oaktree With Maturity in 2027
ReutersJul 25 08:30 ET
Express News | Checkpoint Therapeutics Inc: FDA Has Set a Pdufa Goal Date of December 28, 2024
ReutersJul 25 07:30 ET
Express News | Checkpoint Therapeutics Announces FDA Acceptance of Bla Resubmission of Cosibelimab for the Treatment of Advanced Cutaneous Squamous Cell Carcinoma
ReutersJul 25 07:30 ET

Comments

Trytosaveabit

Jul 19 07:12

Update

$Fortress Biotech(FBIO.US)$ Fortress Biotech's Urica Therapeutics Entered Into An APA Royalty Agreement, Urica Sold The Rights To Its URAT1 Inhibitor Product Candidate In Development For The Treatment Of Gout, Dotinurad, And Related Intellectual Property, Licenses And Agreements To Crystalys Therapeutics In Return For Common Stock Equal To 35% Of Crystalys' Outstanding Equity
- SEC Filing

Trytosaveabit

May 15 15:17

Make a note

$Fortress Biotech(FBIO.US)$ Reuters· just
Fortress Biotech Inc: FDA Accepted Nda Filing for Dfd-29 to Treat Inflammatory Lesions & Erythema of Rosacea in Adults; Pdufa Goal Date of Nov 4, 2024

101539447

Apr 8 07:18

$Fortress Biotech(FBIO.US)$ even after good resilt thus share is going down. holding since last 3 months now.

carlton griffiths

Mar 25 01:50

$Fortress Biotech(FBIO.US)$ 👀 🤔

Moomoo AI

Mar 7 04:29

The low P/S ratio is likely due to investors' concerns about the company's poor revenue performance and underwhelming growth outlook. The company will need a significant change in fortune to justify a higher P/S ratio in the future.

Fortress Biotech, Inc. (NASDAQ:FBIO) Shares Fly 29% But Investors Aren't Buying For Growth